Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis.

作者: H. P. Hoensch , K. Balzer , P. Dylewizc , W. Kirch , H. Goebell

DOI: 10.1007/BF00544371

关键词:

摘要: Six patients with primary biliary cirrhosis (PBC) were treated a daily oral dose of 600 mg rifampicin for 2 weeks to induce the hepatic metabolism drugs and bile acids. On 5 6 experienced pronounced decrease their pruritus. In all oxidative cytochrome P-450 dependent drug was induced as shown by an increase antipyrine-clearance from 36.3±8.8 80.6±20.1 ml/min enhanced urinary excretion 6-β-hydroxycortisol 454±1.99 1607±362 µg/24 h. Furthermore, in serum alkaline phosphatase declined. 3 cholestatic (bilirubin>1.0 mg/dl) concentration total conjugated acids strikingly reduced. Thus, is inducer PBC-patients, ameliorates pruritus can lower concentrations

参考文章(10)
Peter Back, Phenobarbital-induced alterations of bile acid metabolism in cases of intrahepatic cholestasis Journal of Molecular Medicine. ,vol. 60, pp. 541- 549 ,(1982) , 10.1007/BF01724209
Boyer Jl, Klein Pd, Bolt Mg, Stellaard F, Phenobarbital treatment in primary biliary cirrhosis. Differences in bile acid composition between responders and nonresponders. Journal of Laboratory and Clinical Medicine. ,vol. 94, pp. 853- ,(1979)
E. E. Ohnhaus, E. Gerber-Taras, B. K. Park, Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man. European Journal of Clinical Pharmacology. ,vol. 24, pp. 247- 250 ,(1983) , 10.1007/BF00613826
G. Acocella, Clinical pharmacokinetics of rifampicin. Clinical Pharmacokinectics. ,vol. 3, pp. 108- 127 ,(1978) , 10.2165/00003088-197803020-00002
Fumiko Mashige, Kazuhiro Imai, Toshiaki Osuga, A simple and sensitive assay of total serum bile acids Clinica Chimica Acta. ,vol. 70, pp. 79- 86 ,(1976) , 10.1016/0009-8981(76)90007-3
EE Ohnhaus, J Martin, J Kinser, JP Colombo, Enzyme induction and renal function in man. British Journal of Clinical Pharmacology. ,vol. 4, pp. 33- 37 ,(1977) , 10.1111/J.1365-2125.1977.TB00663.X
K von Bergmann, J Fierer, H Y Mok, S M Grundy, Effects of rifampin on biliary lipids in humans. Antimicrobial Agents and Chemotherapy. ,vol. 19, pp. 342- 345 ,(1981) , 10.1128/AAC.19.2.342
JOSEPH R. BLOOMER, Phenobarbital Effects in Cholestatic Liver Disease Annals of Internal Medicine. ,vol. 82, pp. 310- 317 ,(1975) , 10.7326/0003-4819-82-3-310
M. T. Kenny, B. Strates, Metabolism and Pharmacokinetics of the Antibiotic Rifampin Drug Metabolism Reviews. ,vol. 12, pp. 159- 218 ,(1981) , 10.3109/03602538109011084